| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26.6M | +10.9% | +21.1% |
| R&D Expense | $5.5M | +11.4% | -27.0% |
| SG&A Expense | $13.0M | +2.6% | -10.0% |
| Operating Income | -$18.2M | +6.0% | +19.3% |
| Pre-tax Income | -$29.5M | -13.9% | -17.7% |
| Income Tax | -$283K | -132.0% | +89.0% |
| Net Income | -$29.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.2M | +167.0% | +217.2% |
| Accounts Receivable | $34.3M | +7.5% | +1.2% |
| Current Assets | $83.7M | +44.4% | -49.4% |
| Total Assets | $198.6M | +6.3% | -41.0% |
| Current Liabilities | $63.6M | -2.0% | -74.5% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$41.2M | — | — |
| Capital Expenditures | $3.5M | — | — |
| Investing Cash Flow | -$3.5M | — | — |
| Financing Cash Flow | $64.9M | — | — |
| Free Cash Flow | -$44.7M | — | — |
| -9.1% |
| -34.5% |
| EPS (Basic) | -$0.45 | +16.7% | +21.1% |
| $35.4M |
| -5.2% |
| -52.0% |
| Total Liabilities | $183.1M | -1.3% | -49.4% |
| Stockholders' Equity | $15.5M | +1172.2% | +161.6% |